These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 22860700

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Mutations of optineurin in amyotrophic lateral sclerosis.
    Maruyama H, Morino H, Ito H, Izumi Y, Kato H, Watanabe Y, Kinoshita Y, Kamada M, Nodera H, Suzuki H, Komure O, Matsuura S, Kobatake K, Morimoto N, Abe K, Suzuki N, Aoki M, Kawata A, Hirai T, Kato T, Ogasawara K, Hirano A, Takumi T, Kusaka H, Hagiwara K, Kaji R, Kawakami H.
    Nature; 2010 May 13; 465(7295):223-6. PubMed ID: 20428114
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins.
    Ratti A, Buratti E.
    J Neurochem; 2016 Aug 13; 138 Suppl 1():95-111. PubMed ID: 27015757
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Co-aggregation of RNA binding proteins in ALS spinal motor neurons: evidence of a common pathogenic mechanism.
    Keller BA, Volkening K, Droppelmann CA, Ang LC, Rademakers R, Strong MJ.
    Acta Neuropathol; 2012 Nov 13; 124(5):733-47. PubMed ID: 22941224
    [Abstract] [Full Text] [Related]

  • 7. Optineurin is co-localized with FUS in basophilic inclusions of ALS with FUS mutation and in basophilic inclusion body disease.
    Ito H, Fujita K, Nakamura M, Wate R, Kaneko S, Sasaki S, Yamane K, Suzuki N, Aoki M, Shibata N, Togashi S, Kawata A, Mochizuki Y, Mizutani T, Maruyama H, Hirano A, Takahashi R, Kawakami H, Kusaka H.
    Acta Neuropathol; 2011 Apr 13; 121(4):555-7. PubMed ID: 21327942
    [No Abstract] [Full Text] [Related]

  • 8. [Identification of a new causative gene of amyotrophic lateral sclerosis; optineurin].
    Maruyama H.
    Rinsho Shinkeigaku; 2012 Apr 13; 52(1):1-5. PubMed ID: 22260971
    [Abstract] [Full Text] [Related]

  • 9. Multiple Proteinopathies in Familial ALS Cases With Optineurin Mutations.
    Ayaki T, Ito H, Komure O, Kamada M, Nakamura M, Wate R, Kusaka H, Yamaguchi Y, Li F, Kawakami H, Urushitani M, Takahashi R.
    J Neuropathol Exp Neurol; 2018 Feb 01; 77(2):128-138. PubMed ID: 29272468
    [Abstract] [Full Text] [Related]

  • 10. [TDP-43 proteinopathies - from frontotemporal lobar degeneration to inclusion body myositis].
    Kierdaszuk B, Berdyński M, Zekanowski C, Kamińska A.
    Neurol Neurochir Pol; 2012 Feb 01; 46(4):384-91. PubMed ID: 23023438
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Widespread RNA metabolism impairment in sporadic inclusion body myositis TDP43-proteinopathy.
    Cortese A, Plagnol V, Brady S, Simone R, Lashley T, Acevedo-Arozena A, de Silva R, Greensmith L, Holton J, Hanna MG, Fisher EM, Fratta P.
    Neurobiol Aging; 2014 Jun 01; 35(6):1491-8. PubMed ID: 24462217
    [Abstract] [Full Text] [Related]

  • 13. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.
    Mackenzie IR, Bigio EH, Ince PG, Geser F, Neumann M, Cairns NJ, Kwong LK, Forman MS, Ravits J, Stewart H, Eisen A, McClusky L, Kretzschmar HA, Monoranu CM, Highley JR, Kirby J, Siddique T, Shaw PJ, Lee VM, Trojanowski JQ.
    Ann Neurol; 2007 May 01; 61(5):427-34. PubMed ID: 17469116
    [Abstract] [Full Text] [Related]

  • 14. TDP-43 and FUS/TLS: sending a complex message about messenger RNA in amyotrophic lateral sclerosis?
    Strong MJ, Volkening K.
    FEBS J; 2011 Oct 01; 278(19):3569-77. PubMed ID: 21810174
    [Abstract] [Full Text] [Related]

  • 15. Connecting RNA-Modifying Similarities of TDP-43, FUS, and SOD1 with MicroRNA Dysregulation Amidst A Renewed Network Perspective of Amyotrophic Lateral Sclerosis Proteinopathy.
    Pham J, Keon M, Brennan S, Saksena N.
    Int J Mol Sci; 2020 May 14; 21(10):. PubMed ID: 32422969
    [Abstract] [Full Text] [Related]

  • 16. Clinicopathologic study on an ALS family with a heterozygous E478G optineurin mutation.
    Ito H, Nakamura M, Komure O, Ayaki T, Wate R, Maruyama H, Nakamura Y, Fujita K, Kaneko S, Okamoto Y, Ihara M, Konishi T, Ogasawara K, Hirano A, Kusaka H, Kaji R, Takahashi R, Kawakami H.
    Acta Neuropathol; 2011 Aug 14; 122(2):223-9. PubMed ID: 21644038
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. TAR DNA-Binding protein 43 accumulation in protein aggregate myopathies.
    Olivé M, Janué A, Moreno D, Gámez J, Torrejón-Escribano B, Ferrer I.
    J Neuropathol Exp Neurol; 2009 Mar 14; 68(3):262-73. PubMed ID: 19225410
    [Abstract] [Full Text] [Related]

  • 19. TDP-43 immunoreactivity in neuronal inclusions in familial amyotrophic lateral sclerosis with or without SOD1 gene mutation.
    Tan CF, Eguchi H, Tagawa A, Onodera O, Iwasaki T, Tsujino A, Nishizawa M, Kakita A, Takahashi H.
    Acta Neuropathol; 2007 May 14; 113(5):535-42. PubMed ID: 17333220
    [Abstract] [Full Text] [Related]

  • 20. [Histological data in inflammatory myositis].
    Mikol J, Polivka M.
    Ann Med Interne (Paris); 2001 Nov 14; 152(7):465-79. PubMed ID: 11965088
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.